Microorganisms (Jun 2021)

Discrimination of <i>Bacillus cereus</i> Group Members by MALDI-TOF Mass Spectrometry

  • Viviana Manzulli,
  • Valeria Rondinone,
  • Alessandro Buchicchio,
  • Luigina Serrecchia,
  • Dora Cipolletta,
  • Antonio Fasanella,
  • Antonio Parisi,
  • Laura Difato,
  • Michela Iatarola,
  • Angela Aceti,
  • Elena Poppa,
  • Francesco Tolve,
  • Lorenzo Pace,
  • Fiorenza Petruzzi,
  • Ines Della Rovere,
  • Donato Antonio Raele,
  • Laura Del Sambro,
  • Luigi Giangrossi,
  • Domenico Galante

DOI
https://doi.org/10.3390/microorganisms9061202
Journal volume & issue
Vol. 9, no. 6
p. 1202

Abstract

Read online

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry (MALDI-TOF MS) technology is currently increasingly used in diagnostic laboratories as a cost effective, rapid and reliable routine technique for the identification and typing of microorganisms. In this study, we used MALDI-TOF MS to analyze a collection of 160 strains belonging to the Bacillus cereus group (57 B. anthracis, 49 B. cereus, 1 B. mycoides, 18 B. wiedmannii, 27 B. thuringiensis, 7 B. toyonensis and 1 B. weihenstephanensis) and to detect specific biomarkers which would allow an unequivocal identification. The Main Spectra Profiles (MSPs) were added to an in-house reference library, expanding the current commercial library which does not include B. toyonensis and B. wiedmannii mass spectra. The obtained mass spectra were statistically compared by Principal Component Analysis (PCA) that revealed seven different clusters. Moreover, for the identification purpose, were generated dedicate algorithms for a rapid and automatic detection of characteristic ion peaks after the mass spectra acquisition. The presence of specific biomarkers can be used to differentiate strains within the B. cereus group and to make a reliable identification of Bacillus anthracis, etiologic agent of anthrax, which is the most pathogenic and feared bacterium of the group. This could offer a critical time advantage for the diagnosis and for the clinical management of human anthrax even in case of bioterror attacks.

Keywords